Iodide

Iodide

SCHEMBL30547352

CC(C)(N)CCCCC=O.I

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
HIF1A Q16665 1/20 0.41
FAAH O00519 2/20 0.38
TRPV1 Q8NER1 2/20 0.38
GRM4 Q14833 1/20 0.33
ACLY P53396 1/20 0.33
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23535082 0.98 TSHR (0.44) TSHRHIF1AFAAHTRPV1GRM4
Hydrochloric Acid SCHEMBL29896516 0.95 TSHR (0.42) TSHRHIF1AFAAHTRPV1GRM4
Bromide SCHEMBL30547353 0.95 TSHR (0.42) TSHRHIF1AFAAHTRPV1GRM4
SCHEMBL22548448 0.90
SCHEMBL12491069 0.79
Iodide SCHEMBL28870826 0.78 TSHR (0.44) TSHRHIF1AFAAHTRPV1ACLY
Hydrochloric Acid SCHEMBL13729232 0.77
SCHEMBL1784550 0.77 TSHR (0.48) TSHRHIF1AFAAHTRPV1ACLY
SCHEMBL5443031 0.76 GRM4 (0.41) GRM4
SCHEMBL1783238 0.75 TSHR (0.52) TSHRHIF1AFAAHTRPV1ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035392-A1 SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES ADVANSIX RESINS & CHEMICALS LLC (US) 2026-02-05 US disclosed
US-12466846-B2 Siloxane derivatives of amino acids having surface-active properties ADVANSIX RESINS & CHEMICALS LLC (US) 2025-11-11 US disclosed
US-20250057955-A1 SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-20 US disclosed
US-20250057749-A1 SURFACTANTS FOR USE IN PERSONAL CARE AND COSMETIC PRODUCTS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-20 US disclosed
US-20250051643-A1 SURFACTANTS FOR ELECTRONICS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-13 US disclosed
US-20230265112-A1 SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES ADVANSIX RESINS & CHEMICALS LLC (US) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250057749-A1 SURFACTANTS FOR USE IN PERSONAL CARE AND COSMETIC PRODUCTS CUTA, SMURF1, PLOD3 TSHR 1489/4885HIF1A 3018/4885FAAH 1713/4885
US-20230265112-A1 SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES BCAT1, PCMT1, LTN1 TSHR 4450/4885HIF1A 3932/4885FAAH 4214/4885
US-20250051643-A1 SURFACTANTS FOR ELECTRONICS STOM, ESPL1, SMURF1 TSHR 3113/4885HIF1A 3418/4885FAAH 1457/4885
US-12466846-B2 Siloxane derivatives of amino acids having surface-active properties BCAT1, PCMT1, LTN1 TSHR 4450/4885HIF1A 3932/4885FAAH 4214/4885
US-20260035392-A1 SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES BCAT1, BCAT2, SLC43A1 TSHR 2235/4885HIF1A 3158/4885FAAH 2934/4885
US-20250057955-A1 SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS S100P, DSG1, TMSB10 TSHR 3295/4885HIF1A 2086/4885FAAH 2255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.